medigraphic.com
ISSN 2078-7162 (Print)

2015, Number 2

<< Back Next >>

Rev Cub de Med Fis y Rehab 2015; 7 (2)

Utility of the treatment with current Kotz and magnetic bed in patient with metabolic syndrome

Matienzo PY, Pérez RZM, Arpa GÁM, Morales JEL

Language: Spanish
References: 20
Page: 138-148
PDF size: 135.21 Kb.


ABSTRACT

Objective: to determine the utility of the treatment with average Kotz and magnetic fields in patient with metabolic syndrome.
Method: a cuasiexperimental study in 30 patients with the clinical diagnosis and of laboratory of metabolic syndrome coming from the consultation of Internal Medicine, at the university hospitals: "Dr. Carlos J. Finlay" and "Dr. Luis Díaz Soto". The patients only talked to magnetic bed in abdomen to 20Hz and average Kotz two circuits at the same time in the rectums abdominal 15 min each one in 30 treatment sessions. Before and after the treatment he/she was carried out physical exam (do I weigh, does it carve, the abdominal circumference and arterial tension), and were they indicated complementary (glycemia, cholesterol, triglycerides and uric acid). The quantitative prosecution (half arithmetic, medium, variance and standard deviation) and qualitative (frequency and percentage), was Chi-square used and does t prove? 0,05 and Odds Ratio.
Results: after the treatment the 86,7% of the patients had figures of arterial tension, it diminished the weight in 4,48 kg, the circumference abdominal 9,3cm, the index of corporal mass 1,6 Kg/m2, the glycemia 1,11 mmol/L, the cholesterol 1,32 mmol/L, the triglycerides 0,58 mmol/L and the acid uric 49,64 mmol/L being statistically significant.
Conclusions: the magnetic therapy and the average Kotz went useful when diminishing or to normalize in most of the patients the arterial tension, the weight, the index of corporal mass and the abdominal circumference, also diminished or it normalized the laboratory variables in single 30 treatment sessions.


REFERENCES

  1. Laclaustra M, Bergua C, Pascual I, Casasnovas JA. Síndrome metabólico. Concepto y fisiopatologia. Rev Esp Cardiol. 2005; 5:3-10.

  2. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in white, black and hispanic americans. Ann Epidemiol. 2000; 10:263-70.

  3. Luengo Fernández E, Ordóñez B, Bergua C, Laclaustra M. Obesidad, dislipidemia y síndrome metabólico. Rev Esp, Cardiol. 2005; 5:21-9.

  4. Campillo Acosta D, Berdasquera Alonso D, Coronado Mestre R. Mortalidad asociada al síndrome metabólico. Rev Cubana Med Gen Integr 2007,23(2).

  5. Gómez Álvarez J. El síndrome metabólico y el entrenamiento físico como pilar importante de su tratamiento. Rev Cubana Cardiol Cir Cardiovasc. 2010,16(1):51- 63.

  6. Miguel PE. El síndrome metabólico: un alto riesgo para individuos sedentarios. ACIMED. 2009; 20(1).

  7. Canöz M, Erdenen F, Uzun H, Müderrisglu C, Aydin S. The relationship of inflammatory cytokines with asthma and obesity. Clin Invest Med. 2008; 31(6):373-379.

  8. Reaven, G. M. The metabolic syndrome: time to get off the merry-go-round? Journal of Internal Medicine, 2011. 269:127–36.

  9. Pérez Fariñas L, Pérez Rodríguez ZM, Mora González SR, Guerrero Delgado L. Tratamiento de pacientes con obesidad abdominal como prevención o progresión del síndrome metabólico. Rev Cubana Med Fis Rehab. 2014 Sep.; 6(1) Disponible en: http://bvs.sld.cu/revistas/mfr/vol6n1_14/mfr04114.htm

  10. Martín Cordero J. Agentes físicos terapéuticos. Editorial Ciencias Médicas. 2008. Cap. 26: 379-409.

  11. Andrew M, Matthew J, Mc Queen. Metabolic syndrome and risk of acute myocardial infartion. J Am Col Cardiol. 2010:55(21).

  12. Alegría E, Castellano J, Alegría A. Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica. Rev Esp Cardiol. 2008; 61(7):752-64.

  13. Arpa Gámez A, González Sotolongo, O, Feliciano Álvarez O, Ferrer López V, Suárez Iznaga R. Síndrome metabólico como factor de riesgo en la enfermedad cerebrovascular. Rev Cubana Med Milit. 2005,34 (4).

  14. Quirantes Moreno AJ; López Ramírez M; Hernández Meléndez E; Pérez Sánchez A. Estilo de vida, desarrollo científico-técnico y obesidad. Rev Cubana Salud Pública. 2009; 35(3).

  15. Sartorio A, Maffiuletti NA, Agosti F, Lafortuna CL. Gender-related changes in body composition, muscle strength and power output after a short-term multidisciplinary weight loss intervention in morbid obesity. J Endocrinol Invest. 2005; 28(6):494-501.

  16. González Sotolongo O, Arpa Gámez A. Eficacia del metformín en el tratamiento de pacientes con síndrome metabólico y disfunción endotelial. Rev Cubana Med Mil. 2011Jul-Dic;40(3-4)2011.

  17. Venereo Gutiérrez JR, Dambay Torres A, Deschapelles Himely E .Pacientes con obesidad exógena en la consulta externa del Instituto Superior de Medicina Militar "Dr. Luis Díaz Soto" Rev Cubana Med Mil. 2005 sep.-dic;20(4).

  18. Tarkhan-Mouravi ID, Purtseladze NA. Influence of treatment with variable magnetic field of low frequency in low mountain environment on cardio hemodynamic index of patients with arterial hypertension. Georgian Med News. 2006 Jun;(135):109-13.

  19. Okano H, Ohkubo C. Exposure to a moderate intensity static magnetic field enhances the hypotensive effect of a calcium channel blocker in spontaneously hypertensive rats. Bioelectromagnetics. 2005 Dec; 26(8):611-23.

  20. Dolgikh VV, Bimbaev AB, Bairova TA, Duĭbanova NV. Impulse iow-intensity electromagnetic field in the treatment of adolescents with essential arterial hypertension. Vopr Kurortol Fizioter Lech Fiz Kult. 2005 Nov-Dec; (6):13-5.




2020     |     www.medigraphic.com